M. Kulyk & Associates, LLC
- SEC CIK
- 0001842370
- Latest filing
- Aug 7, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by M. Kulyk & Associates, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,878
- Value
- $8.03M
- % of portfolio
- 1.3%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,878 | $8.03M | 1.3% | −2,017−13.5% | Reduced | Holders |
| Q1 2026 | 14,895 | $11.5M | 2.1% | +91+0.6% | Added | Holders |
| Q4 2025 | 14,804 | $11.4M | 2.2% | +431+3.0% | Added | Holders |
| Q3 2025 | 14,373 | $8.08M | 1.6% | +10,368+258.9% | Added | Holders |
| Q2 2025 | 4,005 | $2.10M | 0.5% | +1,318+49.1% | Added | Holders |
| Q1 2025 | 2,687 | $1.70M | 0.4% | +528+24.5% | Added | Holders |
| Q4 2024 | 2,159 | $1.54M | 0.3% | +2,159 | New | Holders |